Advertisement DKSH to commercialize GlaxoSmithKline antibiotic product line in Hong Kong - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

DKSH to commercialize GlaxoSmithKline antibiotic product line in Hong Kong

DKSH's Business Unit Healthcare has partnered with GlaxoSmithKline to commercialize antibiotics in medical and trade channels in Hong Kong.

DKSH provides contract sales services in both private clinics and trade channel for the antibiotic product line of GlaxoSmithKline.

GlaxoSmithKline (Hong Kong) vice president and general manager Sally Storey said, "We look forward to a successful partnership for both companies and to help patients to gain access to quality medicine."

DKSH Healthcare, Hong Kong, vice president Richard Holloway said, "To outsource sales and distribution service as part of its product portfolio enables GSK to concentrate on its core competencies while minimizing cost."